- Home
- ALT vs CYH Comparison
ALT vs CYH Comparison
Compare ALT & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | CYH |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 432.2M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALT | CYH |
|---|---|---|
| Price | $2.88 | $2.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $17.67 | $3.57 |
| AVG Volume (30 Days) | ★ 3.2M | 1.3M |
| Earning Date | 03-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.37 | ★ 196.67 |
| EPS | N/A | ★ 3.77 |
| Revenue | $41,000.00 | ★ $12,485,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.17 |
| P/E Ratio | ★ N/A | $0.76 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.91 | $2.24 |
| 52 Week High | $7.73 | $4.43 |
Technical Indicators
Market Signals| Indicator | ALT | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 27.66 | 32.80 |
| Support Level | N/A | $2.41 |
| Resistance Level | $4.25 | $3.25 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 2.55 | 4.90 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.